| MolName | [2-(5-naphthalen-2-yl-3-phenyl-3,4-dihydropyrazol-2-yl)-2-oxoethyl] (E)-3-(5-bromofuran-2-yl)prop-2-enoate |
| MolecularFormula | C28H21N2O4Br |
| Smiles | O=C(COC(/C=C/c(o1)ccc1Br)=O)N(C(C1)c2ccccc2)N=C1c1cc2ccccc2cc1 |
| InChI | InChI=1S/C28H21BrN2O4/c29-26-14-12-23(35-26)13-15-28(33)34-18-27(32)31-25(20-7-2-1-3-8-20)17-24(30-31)22-11-10-19-6-4-5-9-21(19)16-22/h1-16,25H,17-18H2/t25-/m0/s1 |
| InChIK | ROKDXZWPTOCUNK-VWLOTQADSA-N |
| TotalMolweight | 529.389 |
| Molweight | 529.389 |
| MonoisotopicMass | 528.068469 |
| CLogP | 5.765 |
| CLogS | -6.944 |
| H Acceptors | 6 |
| TotalSurfaceArea | 367.49 |
| Relative PSA | 0.17756 |
| PolarSurfaceArea | 72.11 |
| Druglikeness | -0.096071 |
| Mutagenic | high |
| Tumorigenic | high |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | |
| Shape Index | 0.54286 |
| Fragments | 1 |
| Non HAtoms | 35 |
| NonCHAtoms | 7 |
| Electronegative Atoms | 7 |
| StereoCenters | 1 |
| Rotatable Bond | 7 |
| Rings Closures | 5 |
| Small Rings | 5 |
| Aromatic Rings | 4 |
| Aromatic Atoms | 21 |
| Sp3Atoms | 4 |
| Symmetricatoms | 2 |
| StereoCon | racemate |
Click to Load Molecule:
1 - [2-(5-naphthalen-2-yl-3-phenyl-3,4-dihydropyrazol-2-yl)-2-oxoethyl] (E)-3-(5-bromofuran-2-yl)prop-2-enoate | 2 - [2-(5-naphthalen-2-yl-3-phenyl-3,4-dihydropyrazol-2-yl)-2-oxoethyl] (E)-3-(5-bromofuran-2-yl)prop-2-enoate